Community Magazine
CMS approves CAR-T therapy payment, but with significant strings attached. For more details see: https://cllsociety.org/2019/02/cms-approves-car-t-therapy-payment/This is a positive first step, but only the first step. We will be interviewing experts on funding over the next few weeks.I am proud of the small role I played in this by going to CMS and lobbying on behalf of future CAR-T patients.If you want a personal response, or just want to stay in touch, please email me at [email protected]. I have no other way of contacting. Thanks. Stay strong. After all, we are all in this together. And please visit our website: http://cllsociety.org for the latest news and information.
Author's Latest Articles
-
A Matching-Adjusted Indirect Comparison of Acalabrutinib Vs. Zanubrutinib in Relapsed Or Refractory CLL
-
My Personal Decision to Restart My CLL (chronic Lymphocytic Leukemia) Treatment
-
ASH 2022: Adverse Events from BTK Inhibitors in Clinical Trials
-
Dr. Stephan Stilgenbauer on the Evolution of CLL to Richter’s Syndrome from ASH 2022